SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Anthera Pharmaceuticals, Inc. Announces the Phase 2b PEARL-SC Data Has Been Accepted as a Late Breaking Poster Presentation at the American College of Rheumatology/ARHP 2012 Annual Scientific Meeting